Skip to content
Open access

Controlled evaluation of architectural, classifier, and training refinements in MolTrans-based drug-target interaction prediction

Sep 2026 · BMC Bioinformatics · 0 citations

TL;DR

Overall, the results show that classifier design and optimisation account for a substantial portion of the improvement over MolTrans, while the contribution of cross-modal architectural components is optimisation-sensitive and dataset-dependent.

Abstract

Drug–target interaction (DTI) prediction is a central task in computational drug discovery, but performance improvements can be difficult to attribute when architectural modifications and training changes are introduced simultaneously. This study evaluates a Bidirectional Cross-Attention and Global Aggregation DTI model (BCAG-DTI) through eight controlled configurations that separate bidirectional cross-attention, global average–max pooling, classifier design, and optimisation strategy. All principal experiments use fixed training, validation, and test partitions and five matched random seeds on BindingDB, BIOSNAP, and DAVIS. Relative to the MolTrans baseline, the complete BCAG-DTI configuration improves mean area under the receiver operating characteristic curve (AUROC) from 0.8815 to 0.9063 on BindingDB, from 0.8631 to 0.8891 on BIOSNAP, and from 0.8808 to 0.8955 on DAVIS. The corresponding gains in area under the precision–recall curve (AUPRC) are 0.0831, 0.0346, and 0.0619, respectively. Controlled ablation shows that the enhanced classifier achieves the highest mean AUROC on BindingDB and BIOSNAP and the highest mean AUPRC and F1-score on all three datasets, whereas the cross-attention-plus-pooling configuration with enhanced training achieves the highest mean AUROC on DAVIS. The enhanced training strategy also provides substantial improvements, while cross-attention alone reduces performance under the baseline training configuration. In BIOSNAP robustness experiments, BCAG-DTI improves MolTrans for unseen drugs, unseen proteins, and 70–90% missing-interaction settings, whereas its AUROC and F1-score are slightly lower at 95% missing data. As an external same-split reference, CPI-GGS evaluated on the fixed BIOSNAP partitions achieves 0.8619 ± 0.0023 AUROC, 0.8645 ± 0.0042 AUPRC, and 0.7938 ± 0.0028 F1-score, compared with 0.8891 ± 0.0078, 0.8992 ± 0.0067, and 0.8178 ± 0.0094 for BCAG-DTI. This comparison is interpreted in the context of different input preprocessing pipelines and substantial differences in model capacity. Attention case analysis further indicates that cross-attention weights should be treated as model-internal allocation patterns rather than validated binding contacts. Overall, the results show that classifier design and optimisation account for a substantial portion of the improvement over MolTrans, while the contribution of cross-modal architectural components is optimisation-sensitive and dataset-dependent.

Read PDF

Similar papers

#artificial intelligence Preprint Sep 2026

BERT4DTI : BERT-based Model for Predicting Drug-Protein Interactions

Understanding how drugs interact with protein targets is fundamental to drug discovery, drug repurposing and the early identification of promising therapeutic candidates before costly experimental testing. Sequence-based DTI models face three practical limitations: labelled interactions are scarce and unevenly distribu...

Thanina Hamitouch, Khadidja Henni, Abdelkrim Arie et al. · 0 citations
#machine learning Preprint Oct 2026

Beyond Random Splits: Evaluating Drug-Target Affinity Models Under Chemically and Biologically Motivated Distribution Shifts Copy

Drug-target affinity (DTA) prediction is widely used to prioritize candidate compounds before costly experimental screening. DTA models are often compared under a single data split, even though deployment may require extrapolation to new chemical series, new protein targets, or both. We ask whether the distribution shi...

Minjae Chung, Clara Li, M. Muthukumaran et al. · 0 citations
#protein folding Open access Sep 2026

From Predicted Ki to Surrogate IC50: Similarity-Guided Empirical Calibration of Drug–Target Affinity Predictions

A DeepPurpose model to estimate inhibition constants (Ki) from molecular graphs and protein sequences was trained and whether those predictions could be aligned empirically with measured IC50 values without treating Ki and IC50 as interchangeable was asked.

Basel Mansour, S. Dutta, Binil Benny et al. · 0 citations
Review Aug 2026

AI-Driven Drug-Target Interaction Prediction: From Data Representation to Model Design.

A systematic reference for future algorithm design, mechanism exploration, and real-world drug discovery applications for AI-driven DTI prediction methodologies, covering binding theories, task formulations, data representation, model design, translational applications, and unresolved challenges.

Jia-Xuan Hu, Lianlian Wu, Song He et al. · 0 citations
Open access Sep 2026

CAMELEON-AI X v3.0: Enhanced Binding Affinity Prediction Using Stacking Ensemble with Ridge Meta-Learner

Binding affinity estimation is an important computational task in modern drug discovery because it helps prioritize compounds according to their expected interaction strength with protein targets. This study presents CAMELEON-AI X v3.0, a machine-learning framework designed to improve binding affinity prediction on het...

Sahil Dipak Lonkar · 0 citations
Open access Sep 2026

Confidence-Gated Triage: Coupling Drug–Target Affinity and ADME-T Predictions to Prioritise Compounds for Docking

A transparent pre-screen can prioritise compounds ahead of structure-based calculation at a fraction of its cost, and the uncertainty and applicability-domain terms act as an abstention mechanism rather than an accuracy gain, and that abstention is not free.

Gozde Yalcin Ozkat · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.